JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 34:62-69
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by French, J. K.
Right arrow Articles by White, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by French, J. K.
Right arrow Articles by White, H. D.

Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks

John K. French, MB, PhDa, Thomas A. Hyde, MBa, Hitesh Patel, MBa, David J. Amos, MBa, Stephanie C. McLaughlin, PhDa, Bruce J. Webber, DSR (Diagnostic)a and Harvey D. White, MB, DSca

a Cardiovascular Research Unit, Cardiology Department, Green Lane Hospital, Auckland, New Zealand



View larger version (13K):

[in a new window]
 
Figure 1 Late actuarial survival after randomization to receive streptokinase or placebo after myocardial infarction. The log-rank comparison between the streptokinase and placebo groups was p = 0.022. At 5 years survival was 84% (95% confidence interval [CI] 76 to 90) in the streptokinase group and 70% (95% CI 60 to 77) in the placebo group (p = 0.023). At 12 years, survival was 66% (95% CI 55 to 75) in the streptokinase group and 51% (95% CI 41 to 60) in the placebo group (p = 0.022).

 


View larger version (18K):

[in a new window]
 
Figure 2 Late survival after myocardial infarction according to the Thrombolysis in Myocardial Infarction (TIMI) flow grade at 3 to 4 weeks. (A) The log-rank three-way comparisons between TIMI 3, 2 and 0–1 flow, truncated at 1, 5 and 12 years, were p = 0.005, 0.005 and 0.028, respectively. The log-rank two-way comparisons of TIMI 3 versus TIMI 2 flow at 1, 5, and 12 years were p = 0.047, 0.045 and 0.36, respectively. The log-rank two-way comparisons of TIMI 3 versus TIMI 0–1 flow, truncated at 1, 5 and 12 years, were p = 0.001, 0.0009 and 0.006, respectively. The log-rank two-way comparisons of TIMI 0–1 versus TIMI 2 flow, truncated at 1, 5 and 12 years, were p = 0.22, 0.25 and 0.15, respectively. (B) Survival adjusted for the ejection fraction and exercise duration; the log-rank comparisons, truncated at 5 and 12 years, were p = 0.026 and 0.27, respectively.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.